Excited to share our new paper in Psychological Methods: “Machine Learning for Propensity Score Estimation: A Systematic Review and Reporting Guidelines.” Led by Prof. Walter Leite (UF) with 6 co-authors across 6 universities. DOI: doi.org/10.1037/met0...
#CausalML #PropensityScore
#CausalML #PropensityScore
APA PsycNet
doi.org
October 20, 2025 at 4:18 PM
Excited to share our new paper in Psychological Methods: “Machine Learning for Propensity Score Estimation: A Systematic Review and Reporting Guidelines.” Led by Prof. Walter Leite (UF) with 6 co-authors across 6 universities. DOI: doi.org/10.1037/met0...
#CausalML #PropensityScore
#CausalML #PropensityScore
New review to read! Contrast-enhanced CT—Nephrotoxic or not?
➡️ A critical review of propensity-score-adjusted studies
🔗 doi.org/10.1111/joim.70095
#radiology #CT #kidney #nephrotoxic #propensityscore #internalmedicine
➡️ A critical review of propensity-score-adjusted studies
🔗 doi.org/10.1111/joim.70095
#radiology #CT #kidney #nephrotoxic #propensityscore #internalmedicine
April 20, 2026 at 5:18 AM
New review to read! Contrast-enhanced CT—Nephrotoxic or not?
➡️ A critical review of propensity-score-adjusted studies
🔗 doi.org/10.1111/joim.70095
#radiology #CT #kidney #nephrotoxic #propensityscore #internalmedicine
➡️ A critical review of propensity-score-adjusted studies
🔗 doi.org/10.1111/joim.70095
#radiology #CT #kidney #nephrotoxic #propensityscore #internalmedicine
Just published in #Infection (#OpenAccess) likely the largest (retrospective multicenter) cohort so far comparing #Meropenem_Vaborbactam and #Ceftazidime_Avibactam for #KPC infections (#BSI and #pneumonia) in #ICU #patients.
link.springer.com/article/10.1...
#Italy #IDSky #PropensityScore
link.springer.com/article/10.1...
#Italy #IDSky #PropensityScore
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study - Infection
Infection - Meropenem/vaborbactam (M/V) and ceftazidime/avibactam (C/A) are considered key agents in treating KPC-producing Klebsiella pneumoniae (Kp) infections. We compared these two drugs in...
link.springer.com
July 16, 2025 at 1:56 PM
Just published in #Infection (#OpenAccess) likely the largest (retrospective multicenter) cohort so far comparing #Meropenem_Vaborbactam and #Ceftazidime_Avibactam for #KPC infections (#BSI and #pneumonia) in #ICU #patients.
link.springer.com/article/10.1...
#Italy #IDSky #PropensityScore
link.springer.com/article/10.1...
#Italy #IDSky #PropensityScore
We compared the early adjuvant treatment outcomes of IV lacosamide and levetiracetam for status epilepticus after benzodiazepine use.
doi.org/10.1002/epi4...
#epilepsy #ILAE #epilepsiaopen #antiseizuremedication #diagnosisprocedurecombination #overlapweighting #propensityscore #seizure
doi.org/10.1002/epi4...
#epilepsy #ILAE #epilepsiaopen #antiseizuremedication #diagnosisprocedurecombination #overlapweighting #propensityscore #seizure
November 17, 2025 at 4:26 PM
We compared the early adjuvant treatment outcomes of IV lacosamide and levetiracetam for status epilepticus after benzodiazepine use.
doi.org/10.1002/epi4...
#epilepsy #ILAE #epilepsiaopen #antiseizuremedication #diagnosisprocedurecombination #overlapweighting #propensityscore #seizure
doi.org/10.1002/epi4...
#epilepsy #ILAE #epilepsiaopen #antiseizuremedication #diagnosisprocedurecombination #overlapweighting #propensityscore #seizure
6. We also conducted *several* sensitivity analyses (also checking robustness of #DiffInDiff assumptions): we fit comparative #ITS regression models w/ #GEE, #PropensityScore-weighted models, & augmented #SyntheticControl models w/ state-level summaries (proportions or means)...
November 11, 2024 at 5:10 PM
6. We also conducted *several* sensitivity analyses (also checking robustness of #DiffInDiff assumptions): we fit comparative #ITS regression models w/ #GEE, #PropensityScore-weighted models, & augmented #SyntheticControl models w/ state-level summaries (proportions or means)...